Annual CFF
$208.40 M
+$53.11 M+34.20%
December 31, 2023
Summary
- As of February 8, 2025, RCKT annual cash flow from financing activities is $208.40 million, with the most recent change of +$53.11 million (+34.20%) on December 31, 2023.
- During the last 3 years, RCKT annual CFF has fallen by -$74.59 million (-26.36%).
- RCKT annual CFF is now -26.36% below its all-time high of $282.99 million, reached on December 31, 2020.
Performance
RCKT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$176.00 K
-$1.35 M-88.50%
September 30, 2024
Summary
- As of February 8, 2025, RCKT quarterly cash flow from financing activities is $176.00 thousand, with the most recent change of -$1.35 million (-88.50%) on September 30, 2024.
- Over the past year, RCKT quarterly CFF has dropped by -$189.31 million (-99.91%).
- RCKT quarterly CFF is now -99.94% below its all-time high of $282.44 million, reached on December 31, 2020.
Performance
RCKT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$3.28 M
-$189.31 M-98.30%
September 30, 2024
Summary
- As of February 8, 2025, RCKT TTM cash flow from financing activities is $3.28 million, with the most recent change of -$189.31 million (-98.30%) on September 30, 2024.
- Over the past year, RCKT TTM CFF has dropped by -$313.17 million (-98.96%).
- RCKT TTM CFF is now -98.97% below its all-time high of $318.99 million, reached on September 30, 2021.
Performance
RCKT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
RCKT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.2% | -99.9% | -99.0% |
| 3 y3 years | -26.4% | -99.9% | -99.0% |
| 5 y5 years | +35.8% | -99.9% | -99.0% |
RCKT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +453.1% | -99.9% | +131.6% | -99.0% | at low |
| 5 y | 5-year | -26.4% | +453.1% | -99.9% | +250.4% | -99.0% | at low |
| alltime | all time | -26.4% | >+9999.0% | -99.9% | +100.7% | -99.0% | +577.6% |
Rocket Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $176.00 K(-88.5%) | $3.28 M(-98.3%) |
| Jun 2024 | - | $1.53 M(+29.2%) | $192.59 M(+0.7%) |
| Mar 2024 | - | $1.18 M(+202.8%) | $191.24 M(-8.2%) |
| Dec 2023 | $208.40 M(+34.2%) | $391.00 K(-99.8%) | $208.40 M(-34.1%) |
| Sep 2023 | - | $189.49 M(>+9900.0%) | $316.45 M(+102.2%) |
| Jun 2023 | - | $182.00 K(-99.0%) | $156.49 M(-9.8%) |
| Mar 2023 | - | $18.34 M(-83.1%) | $173.56 M(+11.8%) |
| Dec 2022 | $155.29 M(+312.1%) | $108.44 M(+267.3%) | $155.29 M(+223.6%) |
| Sep 2022 | - | $29.53 M(+71.2%) | $47.98 M(+6.4%) |
| Jun 2022 | - | $17.25 M(>+9900.0%) | $45.10 M(+55.7%) |
| Mar 2022 | - | $76.00 K(-93.3%) | $28.96 M(-23.1%) |
| Dec 2021 | $37.68 M(-86.7%) | $1.14 M(-95.7%) | $37.68 M(-88.2%) |
| Sep 2021 | - | $26.64 M(+2289.1%) | $318.99 M(+8.9%) |
| Jun 2021 | - | $1.11 M(-87.3%) | $292.86 M(+0.3%) |
| Mar 2021 | - | $8.79 M(-96.9%) | $291.90 M(+3.1%) |
| Dec 2020 | $282.99 M(+59.2%) | $282.44 M(>+9900.0%) | $282.99 M(+204.4%) |
| Sep 2020 | - | $512.00 K(+239.1%) | $92.95 M(+0.5%) |
| Jun 2020 | - | $151.00 K(-229.1%) | $92.47 M(-48.0%) |
| Mar 2020 | - | -$117.00 K(-100.1%) | $177.67 M(-0.1%) |
| Dec 2019 | $177.79 M | $92.41 M(>+9900.0%) | $177.79 M(+11.0%) |
| Sep 2019 | - | $31.00 K(-100.0%) | $160.22 M(-0.1%) |
| Jun 2019 | - | $85.35 M(>+9900.0%) | $160.34 M(+113.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $0.00(-100.0%) | $74.98 M(-51.2%) |
| Dec 2018 | $153.50 M(>+9900.0%) | $74.83 M(>+9900.0%) | $153.50 M(+188.1%) |
| Sep 2018 | - | $149.00 K(>+9900.0%) | $53.28 M(+0.4%) |
| Jun 2018 | - | $0.00(-100.0%) | $53.09 M(-6.8%) |
| Mar 2018 | - | $78.52 M(-409.3%) | $56.99 M(>+9900.0%) |
| Dec 2017 | $19.00 K(-100.0%) | -$25.39 M(>+9900.0%) | $19.00 K(-99.9%) |
| Sep 2017 | - | -$39.00 K(-101.0%) | $25.62 M(-65.5%) |
| Jun 2017 | - | $3.90 M(-81.9%) | $74.34 M(-0.4%) |
| Mar 2017 | - | $21.55 M(>+9900.0%) | $74.63 M(+40.6%) |
| Dec 2016 | $53.08 M(-57.7%) | $213.00 K(-99.6%) | $53.08 M(+0.3%) |
| Sep 2016 | - | $48.69 M(+1064.2%) | $52.94 M(-32.3%) |
| Jun 2016 | - | $4.18 M(>+9900.0%) | $78.22 M(+5.7%) |
| Mar 2016 | - | $0.00(-100.0%) | $74.00 M(-41.0%) |
| Dec 2015 | $125.52 M(>+9900.0%) | $73.00 K(-99.9%) | $125.52 M(-0.9%) |
| Sep 2015 | - | $73.97 M(<-9900.0%) | $126.70 M(+143.5%) |
| Jun 2015 | - | -$40.00 K(-100.1%) | $52.04 M(-0.1%) |
| Mar 2015 | - | $51.51 M(+4004.7%) | $52.08 M(+9069.4%) |
| Dec 2014 | $568.00 K(-96.8%) | $1.25 M(-282.7%) | $568.00 K(-182.7%) |
| Sep 2014 | - | -$687.00 K(<-9900.0%) | -$687.00 K(<-9900.0%) |
| Jun 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00 | $0.00 |
| Dec 2013 | $17.88 M(+615.0%) | - | - |
| Dec 2012 | $2.50 M | - | - |
FAQ
- What is Rocket Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals annual CFF year-on-year change?
- What is Rocket Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals quarterly CFF year-on-year change?
- What is Rocket Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals TTM CFF year-on-year change?
What is Rocket Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of RCKT is $208.40 M
What is the all time high annual CFF for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high annual cash flow from financing activities is $282.99 M
What is Rocket Pharmaceuticals annual CFF year-on-year change?
Over the past year, RCKT annual cash flow from financing activities has changed by +$53.11 M (+34.20%)
What is Rocket Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of RCKT is $176.00 K
What is the all time high quarterly CFF for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high quarterly cash flow from financing activities is $282.44 M
What is Rocket Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, RCKT quarterly cash flow from financing activities has changed by -$189.31 M (-99.91%)
What is Rocket Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of RCKT is $3.28 M
What is the all time high TTM CFF for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high TTM cash flow from financing activities is $318.99 M
What is Rocket Pharmaceuticals TTM CFF year-on-year change?
Over the past year, RCKT TTM cash flow from financing activities has changed by -$313.17 M (-98.96%)